Fernando Hernanz, Noelia González, Maria Esteban, Pedro Muñoz
Breast Unit, Hospital Valdecilla, University of Cantabria, Avda. Valdecilla Sn, 39008, Santander, Cantabria, Spain.
Servicio Cántabro de Salud (SCS), Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain.
Breast Cancer. 2023 Jul;30(4):552-558. doi: 10.1007/s12282-023-01445-6. Epub 2023 Mar 3.
Mastectomy has often been cited as the favoured option for centrally located breast tumours because lumpectomies or quadrantectomies that remove the nipple-areola complex often result in poor cosmesis. Currently, breast-conserving treatment is a preferred treatment for centrally located breast tumours, but this approach requires oncoplastic breast technique to avoid aesthetic sequels. This article describes the use of breast reduction techniques with immediate nipple-areola complex reconstruction (utilised to treat breast cancer) for centrally sited breast tumours PATIENTS: Ten patients suffering from a centrally located breast carcinoma were treated at our breast unit over a period of 16 years (2006-2022). Oncologic and patient-reported outcomes were updated revising electronic reports and surveying with BREAST-Q module Breast conserving therapy (version 2, Spanish) postoperative scales.
Excision margins were complete in all cases. There have been no postoperative complications, all patients are alive and no cases of recurrence after 84.8 months of mean follow-up. Patients score the domain satisfaction with breast: mean 61.7 (Standard deviation 12.5) out of 100.
Breast reduction mammaplasty with immediate nipple-areola complex reconstruction allows surgeons to carry out a central quadrantectomy to treat centrally located breast carcinoma with good oncologic and cosmetic outcome.
乳房切除术常被视为治疗中央型乳腺肿瘤的首选方案，因为切除乳头乳晕复合体的肿块切除术或象限切除术往往会导致美容效果不佳。目前，保乳治疗是中央型乳腺肿瘤的首选治疗方法，但这种方法需要肿瘤整形乳房技术来避免美学后遗症。本文描述了采用乳房缩小技术并立即进行乳头乳晕复合体重建（用于治疗乳腺癌）来治疗中央型乳腺肿瘤。
在16年期间（2006 - 2022年），我们乳腺科对10例患有中央型乳腺癌的患者进行了治疗。通过修订电子报告并使用BREAST - Q模块乳房保乳治疗（第2版，西班牙语）术后量表进行调查，更新了肿瘤学和患者报告的结果。
所有病例切缘均为阴性。术后无并发症发生，所有患者均存活，平均随访84.8个月后无复发病例。患者对乳房领域的满意度评分：平均为61.7（标准差12.5），满分100分。
采用乳房缩小整形术并立即进行乳头乳晕复合体重建，外科医生能够实施中央象限切除术来治疗中央型乳腺癌，获得良好的肿瘤学和美容效果。
